Sarepta Therapeutics taps former Allergan exec as CEO — 4 insights

Sarepta Therapeutics named Douglas Ingram its president and CEO.

Advertisement

Here’s what you should know:

1. Mr. Ingram will serve on the company’s board as well.

2. He has more than two decades of executive leadership experience.

3. Edward Kaye, MD, is stepping down from his leadership positions, but will serve the company in an advisor’s role.

4. Mr. Ingram was president of Allergan until it was acquired by Actavis in 2015.

More articles on improving health:
Successful total joint replacement bundles in ASCs: 2 factors to prioritize
30 things for ASC leaders to know for June
Where ASCs fit in a consolidating marketplace — Is independence an option?

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC News

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.